Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis0q
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 DROC
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation by Technology
6.1 Introduction
6.2 Immunochemistry
6.3 Molecular diagnostics
6.4 Clinical chemistry
6.5 Clinical Microbiology
6.6 Hematology
6.7 Coagulation and Hemostasis
Chapter 7 Market Segmentation by Product & Service
7.1 Introduction
7.2 Reagents & kits
7.3 Data management software services
7.4 Instruments
7.5 Consumables
Chapter 8 Market Segmentation by End-user
8.1 Introduction
8.2 Hospitals
8.3 Laboratories
8.4 Patient self-testing
8.5 Academic institutes
8.6 Point-care testing
Chapter 9 Market Segmentation by Application
9.1 Introduction
9.2 Diabetes
9.3 Cancer
9.4 Cardiology
9.5 Drug testing
9.6 Autoimmune disease
9.7 Nephrology
9.8 Infectious disease
Chapter 10 Market Segmentation by Usability
10.1 Disposable IVD devices
10.2 Reusable IVD devices
Chapter 11 Market Segmentation by Geography
11.1 Spain
Chapter 12 Competitive Landscape
12.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
12.2 Market Share Analysis
12.3 Strategies Adopted By Top Companies
Chapter 13 Company Profiles
13.1 Abbott laboratories
13.2 Bio-Rad laboratories
13.3 Siemens healthcare GmbH
13.4 Roche diagnostics
13.5 Qiagen N.V
13.6 Cepheid, Inc.
13.7 Hologic, Inc
13.8 Orasure technologies
13.9 Alere, Inc
13.10 Quidel Corporation
13.11 Biomerieux, Inc.
13.12 Becton, Dickinson and company
Chapter 14 Market Insights
14.1 Insights of Industry Experts
14.2 Analyst Opinion (Market Understanding)
14.3 Investment Opportunities
Chapter 16 Appendix
15.1 List of Tables
15.2 List of Figures
